This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
NEW YORK (
TheStreet) -- All-coach airline
JetBlue Airways(JBLU - Get Report) announced it is adding a business-class cabin that will include 16 lie-flat seats on flights between New York and Los Angeles and San Francisco.
The 16 premium seats will include air cushions with adjustable firmness and massage capabilities, a 15-inch television and a "wake-me-for-service" flight-attendant indicator. They will measure 6 feet, 8 inches when reclined into full, lie-flat position. Four of the 16 seats will have doors and will be dubbed "private suites." JetBlue said 11 of its new Airbus A321 planes will feature the seats in the second quarter of 2014. Planes that include the new seats will accommodate 143 passengers in coach.
JetBlue hasn't yet announced the price of the new premium seats.
United Airlines(UAL - Get Report),
American Airlines and
Delta Air Lines(DAL - Get Report) have all been implementing seats that can fully recline on their transcontinental flights.
Billionaire investor Carl Icahn increased his stake in
Dell (DELL) as a shareholder vote over control of the company approaches.
Icahn disclosed in a regulatory filing late Monday that he purchased an additional 4 million shares in Dell on Thursday, bringing his stake in the company to 8.9% from 8.7%. Icahn purchased the shares on the same day he filed a suit to block a delay in a shareholder vote over control of the company.
Founder Michael Dell and investment firm Silver Lake Partners boosted their buyout bid for the company just one day later. Their bid is currently $13.75 a share, with shareholders receiving a special dividend of 13 cents share. A shareholder vote on the offer is scheduled for Sept. 12.
Icahn has bid $15.50 a share.
CVS Caremark(CVS - Get Report) reported a 16% rise in second-quarter profit that beat Wall Street expectations, driven by new generic drugs, which helped to boost operating profit in pharmacy units.